Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis-Reference-Cited by-同舟云学术

Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis

Published:2019-05-29 Issue:1 Volume:20 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Ye Lin,Pu Chunyun,Tang Jun,Wang Yan,Wang Can,Qiu Zhu,Xiang Tingxiu,Zhang Yunmei,Peng Weiyan

Funder

Major project of Chongqing Municipal Health Commission

Science Commission of Yuzhong District, Chongqing, China

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-019-1071-5.pdf

Reference24 articles.

1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018.

2. Wakelee H, Kelly K, Edelman MJ. 50 years of progress in the systemic therapy of non-small cell lung cancer. Am Soc Clin Oncol Educ Book. 2014:177–89.

3. Keller SM, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern cooperative oncology group. N Engl J Med. 2000;343(17):1217–22.

4. Cao R, et al. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARgamma-SIRT1 feedback loop in human bladder cancer cells. Cancer Lett. 2018;414:278–93.

5. Goodman GE, et al. Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J Clin Oncol. 1990;8(6):1083–92.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma;Advanced Science;2024-04-06

2. Research progress of DDR1 inhibitors in the treatment of multiple human diseases;European Journal of Medicinal Chemistry;2024-03

3. TM4SF19 controls GABP-dependent YAP transcription in head and neck cancer under oxidative stress conditions;Proceedings of the National Academy of Sciences;2024-02-05

4. PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1;Biology Direct;2024-01-17

5. Discoidin domain receptor 1 as a potent therapeutic target in solid tumors;hLife;2024-01